{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Ji S"],"funding":["Ministry of Science and Technology of China","National Natural Science Foundation of China"],"pagination":["923-934"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9794550"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["45(12)"],"pubmed_abstract":["Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have great potential in applications such as regenerative medicine, cardiac disease modeling, and <i>in vitro</i> drug evaluation. However, hPSC-CMs are immature, which limits their applications. During development, the maturation of CMs is accompanied by a decline in their proliferative capacity. This phenomenon suggests that regulating the cell cycle may facilitate the maturation of hPSC-CMs. Aurora kinases are essential kinases that regulate the cell cycle, the role of which is not well studied in hPSC-CM maturation. Here, we demonstrate that CYC116, an inhibitor of Aurora kinases, significantly promotes the maturation of CMs derived from both human embryonic stem cells (H1 and H9) and iPSCs (induced PSCs) (UC013), resulting "],"journal":["Molecules and cells"],"pubmed_title":["The Aurora Kinase Inhibitor CYC116 Promotes the Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells."],"pmcid":["PMC9794550"],"funding_grant_id":["82121005","81730099","2017YFA0104002"],"pubmed_authors":["Ren X","Ji S","Huang C","Ding X","Chen Z","Xie X","Chen Y","He B","Tu W"],"additional_accession":[]},"is_claimable":false,"name":"The Aurora Kinase Inhibitor CYC116 Promotes the Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells.","description":"Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have great potential in applications such as regenerative medicine, cardiac disease modeling, and <i>in vitro</i> drug evaluation. However, hPSC-CMs are immature, which limits their applications. During development, the maturation of CMs is accompanied by a decline in their proliferative capacity. This phenomenon suggests that regulating the cell cycle may facilitate the maturation of hPSC-CMs. Aurora kinases are essential kinases that regulate the cell cycle, the role of which is not well studied in hPSC-CM maturation. Here, we demonstrate that CYC116, an inhibitor of Aurora kinases, significantly promotes the maturation of CMs derived from both human embryonic stem cells (H1 and H9) and iPSCs (induced PSCs) (UC013), resulting ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Dec","modification":"2025-04-04T19:09:13.001Z","creation":"2025-04-04T19:09:13.001Z"},"accession":"S-EPMC9794550","cross_references":{"pubmed":["36572561"],"doi":["10.14348/molcells.2022.0077"]}}